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Abstract—Although developments in modern medicine con-
tinue to reduce premature death from acute illnesses, chronic
diseases are now pervading the resultant aging population at
a growing rate. Such diseases cannot be cured with drug-
based treatment, but can be controlled with patients’ regular
monitoring of their symptoms and consequent lifestyle changes.
However, this level of sustained engagement outside face-to-
face appointments places a considerable burden upon patients.
Smartphones are suitable platforms to support both patients in
engaging with self-management plans, and clinicians in directly
monitoring the influence of these plans. Bespoke applications
exist for such purposes, yet the diversity in patients’ lifestyles
and levels of engagement necessitates many new or personalised
applications. One approach, to solve these problems at scale,
is with end-user development. This paper reports the findings
from interviews with clinicians, and ethnographic observation
in chronic disease management clinics, to derive requirements
of end-user development technology to support clinicians and
patients in tailored management of their diseases. Time and
quality are key factors towards stakeholders’ acceptance of
chronic disease management with end-user development.
I. INTRODUCTION
Medical research continues to fight a winning battle against
acute deadly diseases. However, the global reduction of acute
infectious diseases such as smallpox, malaria, measles and
polio, has increased overall life expectancy, giving rise to a
dramatic increase in the problem of chronic diseases. Ac-
cording to the World Health Organization (WHO), global
life expectancy increased by 5.5 years from 2000 to 20161.
In parallel, almost 60% of worldwide deaths and 43% of
the global disease burden are attributed to chronic diseases
- figures expected to rise to 73% of deaths and 60% of
global disease burden by 20202. With a disparate range of
causal factors, various social and economic influences, and no
clearly delineated solution, this chronic disease pandemic is,
by definition, a “wicked problem”.
Technological innovations have transformed the effective-
ness of healthcare around the world. Examples such as MRI
scanners, laser eye surgery, or bionic hands may spring to
mind, but these are undisputed solutions to “tame problems”.
In this paper, we instead draw attention to technology that
can support human-centred communication and collaboration
towards developing better approaches to patient management.
From an organisational perspective, patient records and pre-
scriptions can be digitised for ease of access and transfer
across different practitioners. In terms of diagnostics, wearable
devices that quantify and summarise health data such as blood
pressure and heart rate can be used to monitor patients more
effectively. Smartphone apps are now being developed that can
trigger emergency actions based on physiological data, such
as automatically calling emergency services when the onset
of a heart attack is detected [1]. The expanding opportunities
afforded by mobile health technology have even empowered
patients to monitor and manage their own conditions, inde-
pendent of clinician involvement. With increasing hospital
waiting times, and the prevalence of chronic diseases in the
global population, the UK’s National Health Service (NHS)
has already begun to act on these potential benefits, through
introduction of an NHS-certified app library3.
While bespoke apps can help chronic disease patients
control their symptoms and effectively provide a solution
at an individual scale, the diversity in symptoms, lifestyles,
socio-economic status, and self-efficacy of these patients in
managing their conditions, all preclude a “one-size-fits-all”
app solution. Thus, we propose that this problem is ideally
suited to end-user development (EUD) technology, where
flexible software can be tailored to the requirements of its end-
users and adapted dynamically as required. Allowing clinicians
to collaborate in the development of disease management apps,
personalised to individual patients, would enable a human-
centred approach to solving this problem. Indeed, sufficiently
motivated patients could themselves engage in EUD activities.
The contribution of this paper is a qualitative analysis of
clinician interviews, and observation of nurses running chronic
disease management clinics, from which a set of requirements
are derived for EUD technology in the management of drug-
resistant chronic diseases. In particular, our results address:
• Stakeholders’ perceived utility of EUD as a novel form
of human problem-solving (perceived potential)
• Challenges with respect to patient-clinician communica-
tion, as well as inter-clinician communication (workflow
requirements)
1. www.who.int/gho/mortality burden disease/life tables/situation trends text
2. www.who.int/chp/about/integrated cd Accessed 27/06/18
3. https://digital.nhs.uk/nhs-apps-library Accessed 17/03/18
Fig. 1. Various interactions between clinicians, patients, and apps are required
• Organisational factors required to support integration of
this technology into current working practices (facilitat-
ing conditions)
II. RELATED WORK
“The use of mobile and wireless technologies to support the
achievement of health objectives (mHealth) has the potential
to transform the face of health service delivery across the
globe” [2]
This quote from the WHO’s report on mHealth innovations
exemplifies how app-based solutions to health service issues
are being taken seriously by global organisations. Indeed,
there are now over 325,000 health-related apps available for
download [3], provoking concerns about the lack of evidence-
based information in the majority of these apps, and the
associated dangers of misinforming their users [4]. In par-
ticular, we focus on apps for assisting in non-communicable
disease management, which do not directly solve problems
in themselves, but instead facilitate “human problem-solving”
by encouraging self-reflection, and enabling understanding
between patients and clinicians.
A literature review was conducted within computer science
literature databases including the ACM, IEEE, and Scopus
digital libraries, as well as the PubMed Central and APA
PsycINFO databases, using combinations of terms including
‘smartphone’, ‘self-monitoring’, ‘self-management’, ‘experi-
ence sampling’, ‘user-centred’, ‘participatory design’ and ‘rec-
ommendations’. Particular insight was obtained from user-
centred design studies that highlighted stakeholder perceptions
of smartphone apps for self-management, prompting the addi-
tion of the latter three terms.
From this review, a variety of interactions between patients,
clinicians, and apps themselves were proposed, as illustrated
in Figure 1, representing an evidence-based set of features
for general-purpose disease management technology. Arrow
numbers correspond to the following numbered descriptions
of each interaction.
Clinician Interactions
1) Viewing real-time patient data: Instant access to self-
monitored patient data could guide treatment decisions in face-
to-face clinical appointments. Study participants living with
cystic fibrosis [5] and attention disorders [6] both strongly
supported the provision of contextual information to clinicians.
In an evaluation study of an app where such information access
was implemented, pediatricians described how this saved time,
focused appointments, and facilitated communication about
difficult issues during these appointments [7].
2) Updating management plan in real-time: Studies that
cite the benefits of smartphone-based self-management all
describe bespoke apps developed for the specific purpose of
each study. Hence it appears that, although these benefits are
generic and adaptable, their implementations are not. Thus,
the researcher must be able to adapt these features found in
bespoke apps to any study they choose to run. In doing so,
they perform end-user development (EUD) activities. While
there are few studies addressing this interaction, the work of
Tetteroo and Markopoulos addresses EUD for rehabilitation
therapists to design exercises for their patients [8].
3) Providing feedback to patient: In user-centred design
studies of healthcare apps, feedback provision from clinicians
to patients was extensively discussed. Given that clinicians
have very little time outside of scheduled appointments, there
was surprising enthusiasm for this type of interaction. For
example, it was recognised that in-the-moment professional as-
sistance on coping with cancer-related pain, prompted by self-
assessment data, would support sustained engagement with
self-monitoring [9]. Clinicians also suggested that feedback
would not have to be a time-critical intervention, and were en-
thusiastic about providing regular feedback to patients on their
data [10]. In an implemented trial, clinicians valued a feature
allowing response to alerts on patients’ symptoms of potential
heart failure, suggesting that the initial workload involved in
responding to these alerts would be reduced in the long-term
by minimising unnecessary hospital admissions [11].
Patient Interactions
4) Viewing aggregated, collected data: Sophisticated sens-
ing and growing storage capacity of smartphones enable rich
visual charts of objective, historical data to be displayed.
Visual feedback could raise engagement in patients with
chronic health conditions. Participants trialling the MONARCA
system valued both the ability to correlate their moods with
objective data, and to determine the temporal antecedents of
low moods [12]. Users with chronic conditions expressed inter-
est in viewing their passively sensed information, particularly
in the form of visual graphs, supported by participants with
mixed chronic conditions [13] and diabetes [14].
5) Tailoring app to personal preferences: Despite the moti-
vational influence of empowerment to self-manage, maintain-
ing a high level of engagement with apps is still a significant
challenge. mHealth apps are easily removed or forgotten about,
and patients thus must perceive sufficient value from use
if they are to retain engagement. Indeed, recent statistics
illustrate that a quarter of apps downloaded are only used
once4. A balance must be sought between ensuring that app
4. http://info.localytics.com/blog/24-of-users-abandon-an-app-after-one-use
content is based on the input of a professional, while also
respecting the preferences of its end-users. User-centred design
studies of health apps have elicited the importance of flexible
prompt schedules to end-users [15], [16]. Moreover, end-users
also desire the ability to control the content of feedback that
they are provided with [12], [13], as well as the format in
which this feedback is presented [6].
6) Providing feedback to clinician: While visual feedback
and personalisation are both useful features for improving
engagement, certain issues relevant to patient care may require
a direct channel of communication to clinicians. As such,
“healthcare partnership” was an emergent theme in one
focus group study [13]. Focus group participants expressed
a desire to contact clinicians for additional explanation of
their received feedback. Involving clinicians in this “sense-
making” process was proposed to support patients in attaining
maximum benefit from their management plans. Additionally,
individuals with cystic fibrosis identified how self-monitored
data would enable them to provide feedback to clinicians
between appointments [5].
App Interactions
While supporting human problem-solving by definition re-
lies on ensuring humans can make decisions, actions that
can be made automatically by smartphone apps can provide
knowledge for human decision-making at key times.
7) Receiving and classifying data: Self-reports can assess
intentions, attitudes or certain subjective physical symptoms
(such as discomfort or pain). However, an increasing breadth
of information can be objectively assessed from sensors built-
in to the smartphone, or externally worn. In doing so, passively
collected sensor data can minimise self-report burden, provide
researchers with richer information, and enable tailored as-
sessment and intervention strategies. For example, Ben-Zeev
et al. showed that smartphone-sensed geospatial activity and
sleep duration were significantly related to stress levels in a
cohort of young people [17]. Adams et al. review smartphone
sensing for monitoring physiological and behavioural biomark-
ers, providing a comprehensive source of examples [18].
8) Sending alerts to clinician: From knowledge acquired
through subjective and objective data, disease management
apps could inform clinicians of in-the-moment issues or
emergency situations. In many conditions, early detection
of symptomatic pre-cursors can prevent fatal consequences
through clinician intervention. In a user-centred study on app
requirements, clinicians and cancer patients both supported
a feature to alert clinicians when patients reported high
levels of pain [9]. Clinician alerts were also implemented
in a randomised control trial, where physiological readings
transferred to smartphones via Bluetooth, combined with pa-
tients’ symptom reports, alerted clinicians to heart failure pre-
conditions [11]. The trial reported improved health outcomes,
with patients expressing feelings of reassurance and self-
efficacy, and clinicians confirming the utility of alerts.
9) Sending notifications to patient: Interventions could be
dynamically delivered at locations of interest or on physiolog-
ical measures. For example, the Q Sense app deployed tailored
interventions when participants dwelt in identified smoking lo-
cations, with post-study feedback exhibiting positive response
towards location triggers, and tailored messages [19]. For
self-management, users with chronic conditions valued the
possibility of contextual reminders, such as those prompted
at a particular location [5], [16]. One study had participants
describe their physical activity after levels of intense activity,
or extended non-activity, were detected with a smartphone ac-
celerometer [20]. From a healthcare perspective, this increased
self-awareness could promote positive behaviour [21].
Summary
The cited studies employ user-centred design to solve
“tame”, albeit non-trivial problems of developing engaging
healthcare apps for particular conditions. We suggest that for
chronic disease management apps to be effective on a global
scale, the extent to which these features are utilised should
be determined by clinicians and patients themselves, shifting
from design before use to design during use [22].
However, developing EUD tools that support stakeholders
in their current practice, and evaluating the success of these
tools in doing so, are major challenges, which require investi-
gation beyond usability studies. In real-world deployments, an
individual’s interactions with technology are highly dependent
on others who form part of their working practices, and
existing technologies in this environment. These factors are
diverse and dynamic, such that continuous communication and
collaboration are necessary to ensure that deployed technology
evolves with an environment and the people within it. As a
result, the approach taken here was to elicit direct feedback
from clinicians, as the potential users of EUD technology.
III. INTERVIEWS
Semi-structured interviews were conducted with eight prac-
tising clinicians in our university’s school of medicine. In-
terviews took place at the interviewees’ location of choice,
lasted approximately 45 minutes, and were audio recorded.
The recordings were then transcribed, and qualitatively coded
for thematic analysis. Coding was structured based on the
addressed themes specified in the introduction, which were
linked to constructs in validated models of technology ac-
ceptance, specifically the Technology Acceptance Model, as
shown in Figure 2, and the Unified Theory of Acceptance and
Use of Technology [23]. In doing so, factors pertaining to
the real-world adoption of chronic disease management EUD
were identified. The relevant constructs of these models are
perceived usefulness (which is further divided into perceived
potential and workflow requirements) and facilitating condi-
tions. These themes are defined as follows.
1) Perceived potential - Clinicians were given a brief
overview of an existing EUD tool, and asked for
feedback on the perceived utility of EUD for disease
management.
2) Workflow requirements - Clinicians were asked about
their current practices in dealing with patients managing
Fig. 2. The Technology Acceptance Model [25]
TABLE I
PERCEIVED BENEFITS/BARRIERS OF EUD TECHNOLOGY FOR CHRONIC
DISEASE MANAGEMENT, BY CLINICIANS AND PATIENTS
Stakeholder PerceivedBenefit
Associated
Barrier
Patient
Patients more
independent
Incapable patients at
risk of being forgotten
Patients empowered
to self-monitor
Patients are diverse in
self-management needs
Clinician
Clinicians can track
patients’ progress
Diverse data can overload
an individual clinician
Clinicians acquire
more accurate data
Patients may be burdened
by extra self-monitoring
chronic conditions, with emphasis on activities that
would need to be supported.
3) Facilitating conditions - Clinicians discussed the prac-
tical issues of integrating novel technology into an
existing healthcare system.
Although we demonstrated our specific EUD tool, Jeeves,
to clinicians in the interviews, the feedback elicited focused
on broader issues of its integration into an existing healthcare
system. Factors pertaining to existing features of Jeeves are
discussed in further detail in our work with psychology
researchers [24], and instead the hypothetical features derived
in our related work were used as prompts for idea generation
in these interviews.
The clinicians interviewed consisted of five general practi-
tioners (GPs), a pharmacist, an ophthalmologist, and a clinical
psychologist. A diversity of roles, responsibilities, and opin-
ions with respect to patient care were thus exposed.
A. Perceived potential
Although clinicians and patients are two distinct stakehold-
ers, the potential for improved patient health outcomes would
reciprocally benefit the clinicians themselves, in terms of
reducing unnecessary appointments and freeing up clinic time.
However, opinions regarding the effect of smartphone-based
self-management on time were varied, with some clinicians
concerned that their workload would be increased. Potential
benefits and barriers are summarised in Table I.
C4, a GP, explained the benefits of a holistic model of care
that takes patients’ psychosocial issues and lifestyle habits
into account. However, time-constrained appointments, and
pressure to see as many patients as possible, means that
GPs often rely on quick prescriptions of medication to avoid
overrunning on clinic time. A further aggravating issue is that
appointment slots are often used for simple reviews:
“I certainly feel like we do epilepsy reviews face-to-face
which could be done remotely. Because a lot of that is asking
questions or providing advice which actually you don’t need
to physically be in the same room as somebody to do that”
Thus, when face-to-face diagnoses are not required, as in
these epilepsy reviews, self-management technology could
increase appointment slots for acutely unwell patients.
Clinicians further explained that patients were often poor
at reporting their symptoms and summarising their experience
over a number of weeks:
“the doctor sees them every two weeks so then some patients
they tell them ‘how was everything during the two weeks?’,‘Yes
everything was alright’...because then time passes and patients
tend to forget” (C2)
Irrespective of patients’ memory bias, the act of taking
an individual reading in a clinical setting is insufficient to
characterise the overall status of the patient. C8 explained how,
for diabetic patients, a single “HBA1C” reading is relied upon
to derive longitudinal information:
“we’re relying on one single value of this HBA1C so...you
might know that the patient has not been well-controlled but
you don’t know why...”
B. Workflow requirements
Although the perceived potential of EUD technology was
evident from clinicians’ feedback, a number of requirements
were addressed towards the workflows and communication
that would need to be supported. Such requirements, and
barriers in Table I that they would address, are shown in
Table II.
1) Technologies should make it easy for clinical staff
to communicate and collaborate with each other: Chronic
disease patient care is a collaborative effort between GPs and
specialist practice nurses. Clinicians explained how individual
diseases were dealt with by nurses who had received specific
training for management of that disease. Patients may also see
different doctors, so it is important to enable collaboration and
understanding between clinicians. Current technology does not
provide a simple means of doing so, as expressed by C3, a
clinical psychologist:
“if we make a change to patients’ medication, the quickest
way to communicate that to the GP is to fax them, would you
believe. So, if we email the GP, we have no idea when the GP
might pick that up” (C3)
It also emerged that comorbidities would need to be taken
into account. Patients with a chronic disease such as diabetes
often have a coexisting disease such as asthma or hypertension.
While one nurse would be capable of authoring an action plan
for managing a patient’s diabetes, this would require input
from an asthma nurse if such a comorbidity was present.
2) Technologies should support patients’ current self-
monitoring: Clinicians also expressed positive opinions with
respect to the feasibility of self-monitoring, given that many
patients are already engaged in doing so. It emerged that
TABLE II
EUD WORKFLOW REQUIREMENTS FOR INTERVIEWED CLINICIANS
EUD Support Barrier Addressed Functionality Required
Clinician
collaboration
Patients are managed
by many clinicians who
need specific types of data
Community support,
including shared editing
+ collaboration functions
Monitoring
Integration
Patients may be burdened
by additional work on top
of current self-monitoring
Simple integration with
existing monitoring
equipment and routines
Individual
Tailoring
Patients are diverse
in their personal
management needs
Protocols that are
tailored to stages
of patient independence
Personalised
Reminders
Dependent, incapable
patients are at risk of
being forgotten
Prompts delivered at
times personalised
to patients’ preferences
patients with chronic diseases are often highly skilled in their
management, and willingly purchase monitors to facilitate
their independence. In order for new technologies to become
an asset to their healthcare, rather than a burden, it should be
possible to integrate technologies with patients’ current self-
monitoring practices. It was suggested that Bluetooth and other
wireless data transfer technology could enable patients’ results
to be seamlessly uploaded from their existing devices.
3) Technologies should allow tailoring to individual pa-
tients: A patient-centred care approach relies on the incor-
poration of patients’ own goals, motivations and constraints,
which determine whether or not they are likely to engage in
treatment. C6 described these factors as the patient’s “agenda”:
“Healthcare people, not just doctors, have agendas, but the
patients often come in with a totally different agenda, so it’s
about sorting out what the patient’s agenda is and how you
can use that to improve their physical wellbeing.”
4) Technologies should support personalised reminders:
For the inevitable cohort of patients who would not engage in
self-monitoring, it should be simple to set up reminders for
different aspects of their healthcare. C3 mentioned that either
patients themselves, or their carers, would add appointment
reminders on their mobile devices.
“Interestingly quite a few of our patients say they’ve set
reminders on their phone for things like daily reminders of
it’s time to take their medication. So they’ve actually done
that themselves, or somebody’s usually done it for them...”
Additionally, many of these patients are required to take
medication at particular times in their daily routine. C8 sug-
gested that it should be possible for patients to input their
waking and sleeping times, as well as regular mealtimes, to
ensure that medication is taken.
C. Real-world integration
In the context of clinical practice, constraints imposed by the
NHS present significant barriers to EUD adoption in the UK.
Healthcare transformation is difficult in a system where it must
take place at a national level. Thus, facilitating conditions must
be fulfilled to enable the transition from clinicians’ intention
to use to their active usage behaviour [23].
1) Clinicians must be allowed time to get used to new
technologies: Although time was a critical factor across all
clinicians, GPs in particular reported a lack of time given their
high workload. Ironically, clinicians would struggle to adopt
time-saving technology because the initial time to introduce it
would be too costly, as expressed by C4:
“...I know that takes like a minute or two, it’s a minute or
two I might not have. The times are very very precious...this
will free up time ultimately. But it’s that initial jump, isn’t it?”
GPs expressed frustration that, paradoxically, they need
more time to discuss general health management that would
reduce unnecessary appointments. However, this high number
of appointments forces them to limit individual patient time
to 10 minutes.
2) Clinicians must trust the resilience of apps developed
with EUD: From a technical perspective, clinicians were wary
about the reliance on technology to capture abnormalities and
give patients immediate feedback at critical times. Quality
assurance of smartphone apps is critical in a medical context,
where the health and well-being of patients could potentially
be put at risk. Clinicians had concerns about what would
happen if such an app were to malfunction:
“if suddenly you don’t have network coverage, then your
reading might not get to the platform or whatever or the server
in two hours, and then if it’s a high reading...you might not
be able to receive the message soon enough” (C8)
In summary, the clinician interviews gave further insight
into the types of interactions that would be required to
support effective human problem-solving in chronic disease
management. In order to strengthen the ecological validity of
these findings, it was necessary to observe the current practices
of clinicians involved in this domain.
IV. OBSERVATION
An observation session was conducted over two hours at a
local clinical practice, with one hour assigned to both a nurse
running a diabetes clinic, and a nurse running a hypertension
clinic. Within each hour, three patients were seen by both
nurses. Audio recordings and computer use were not permitted
within the clinical setting. Instead, notes were hand-written
during the observation sessions, transcribed and expanded on
within 24 hours of the recording process. The observation
sessions were naturalistic, in that the observation aimed to
disrupt the process as little as possible.
A. Diabetes management clinic
The observations made during the diabetes management
clinic are divided into the following themes: self-management,
salient problems, and technology use.
1) Self-management: The nurse explained that, contrary to
the stereotype of older patients being less accepting of patient-
centred care, diabetic patients of all ages are proactive in self-
monitoring their conditions, and often enthusiastic in doing
so. Patients are required to carry electronic glucose monitors
with them, in order to ensure that their levels are safe prior
to driving or engaging in other activities that would require
TABLE III
CLINIC OBSERVATIONS AND THEIR RELATION TO WORKFLOW REQUIREMENTS
Observation Patients are already self-monitoring, but have to bring their readings on paper
Implication Allowing patients to synchronise readings on their various electronic monitors would improve the process for patients and reduce errors
Requirement Technologies should support patients’ current self-monitoring
Observation Patients’ medication details and recent results are not always synchronised
Implication New technology in clinical practice would ideally allow clinicians to immediately view updates made by another clinician
Requirement Technologies should make it easy for clinical staff to communicate and collaborate with each other
Observation Patients are burdened with keeping track of many responsibilities
Implication A function to send time-based or context-sensitive reminders could improve appointment and medication adherence
Requirement Technologies should support personalised reminders
Observation Failure to remember medication or monitoring equipment could be life-threatening
Implication If clinicians develop reminder prompts for patients, it is vital that these arrive consistently if patients’ health is at stake
Requirement Clinicians must trust the resilience of apps developed with EUD technologies
Observation Clinical nurses have very little time in between appointments
Implication If nurses are going to employ EUD to save future time, they must be allocated scheduled time to monitor patients and track compliance
Requirement Clinicians must be allowed time to get used to new technologies
Observation Patients have a variety of comorbidities, requirements and personal schedules
Implication A generic management app may not be appropriate for diverse requirements of comorbid patients with individual demands
Requirement Technologies should allow tailoring by individual patients
concentration, which these patients accept as part of their
management regime. As previously mentioned by clinicians,
patients often purchase their own monitors for home use.
2) Problems: Contrary to the expectation of non-
compliance with self-monitoring, patients are highly compli-
ant, but face barriers in terms of memory and information
overload. Two of the three patients had their medication
reviewed, revealing a considerable number of drugs for manag-
ing comorbidities present in these patients. The nurse required
clarification from patients on medication they were currently
taking, as medication lists are sometimes not synchronised
across the practice. When these discrepancies are not checked,
this can result in patients reordering unnecessary prescriptions.
3) Technology: In terms of resources, patients were pro-
vided with a self-management plan on paper. The nurse
explained that while patients were generally enthusiastic about
a personalised plan, the paper often got misplaced, so that the
nurse would keep a copy herself to use for discussion with
patients. Indeed, technology use was limited to the nurse’s
patient management application. She described how some
clinics send patients SMS appointment reminders, but that this
is at the discretion of the clinic’s management, and due to the
logistics of implementation, is uncommon.
B. Hypertension management clinic
The hypertension management clinic had a similar format to
that of the diabetes clinic, involving a nurse with expertise in
hypertension, who saw three patients for their annual reviews.
1) Self-management: Despite similar difficulties to the di-
abetic patients in independent management of their treatment,
hypertension patients also appeared to be proactive in doing
so. All three patients were satisfied with monitoring their
blood pressure readings every day, expressed interest in the
results, and engaged in active discussion with the nurse, rather
than passively receiving information. The nurse explained that
patients frequently get white coat hypertension - the artificial
raising of blood pressure readings caused by the unfamiliar
clinical environment. To alleviate this, they are encouraged
to take their blood pressure readings at home, in a familiar
context that provides the most accurate results.
2) Problems: Forgetfulness, particularly in medication
management, was a pertinent issue noted during observation in
two older patients. As discussed in the diabetes clinic, patients
would order unnecessary medication, due to lack of commu-
nication between clinical staff. One patient was unsure of the
medication she was regularly taking. The nurse was required
to go through this patient’s list of medication, asking which
were actually necessary. Although appointment reminders
were sometimes made via phone calls, this placed additional
responsibility on nurses beyond their standard schedule.
3) Technology use: The use of technology again appeared
to be limited to the nurse’s patient management applica-
tion, which did not integrate well with patients’ paper-based
readings, as previously described in the manual transcription,
scanning and uploading of patient results. The nurse described
a new system for prescription management, whereby patients
receive a text message to remind them that their prescription
is due. The system has so far received a positive response
from patients, but is limited to prescriptions and does not take
into account regularly scheduled appointments, or reminders
to take medication, for example.
C. Summary
These observations are not an in-depth ethnographic study
but instead served as a source of triangulation with clinician
interviews. Table III summarises observations, their implica-
tions, and the requirements derived from interviews that they
support, described in detail as follows.
The between-patient variation in skills and requirements
necessitates individually tailored apps. However, within-patient
differences of knowledge and proactive behaviour over time
indicate the utility of allowing patients to tailor their apps in-
dependently. Recently diagnosed patients require considerable
education and reminders to engage in treatment, but over time,
their self-efficacy increases such that monitoring and medi-
cation become routine activities. Thus, continuous reminders
from an app at this stage are likely to be irritating and intrusive.
Allowing patients to adjust the level and type of reminders
as necessary would therefore be beneficial, represented by
the requirement that “technologies should allow tailoring by
individual patients”.
The laborious transfer from paper to electronic health
records could be alleviated for nurses, but if patients have to do
their own transfer of readings from glucose or blood pressure
monitors into new technologies, there still exists labour on
their part. Further, the requirement that “technologies should
support patients’ current self-monitoring” could also stream-
line this process for patients themselves.
This difficulty in information transfer was also present
between nurses and other clinicians. For example, changes to
medication initiated by GPs were not immediately communi-
cated through the clinic’s system, such that nurses relied on
patients to provide up-to-date information. Accessing results
such as blood tests also appeared to be a time-consuming
process for nurses. This difficulty in communication was
highlighted through interviews, motivating the requirement
that “technologies should make it easy for clinical staff to
communicate and collaborate with each other”.
Allowing patients and nurses to work together to schedule
reminders on patients’ devices for medication, appointments,
and emergency equipment could be a useful feature, consis-
tent with the requirement that “technologies should support
personalised reminders”. As an example, a prompt could be
issued to a patient when they leave their home to remind
them to take appropriate equipment with them. This further
links with the importance of app reliability. Ensuring that
reminders are sent to patients consistently is of particular
importance, such that “clinicians must trust the resilience
of apps developed with EUD technology”.
The adoption of problem-solving technology must not im-
pose additional burden on clinicians in its use. Although
empowering patients to take responsibility for their healthcare
would reduce the burden of unnecessary or missed appoint-
ments, it appears that the primary barrier to the adoption of
novel technology is the initial burden of introduction. Nurses
are still constrained by time, and as such are unlikely to mon-
itor patients’ self-reported readings in between appointments
unless specific time was allocated for them to do so. This
supports the requirement that “clinicians must be allowed time
to get used to new technologies”.
V. DISCUSSION
For clinicians to adopt new problem-solving technologies in
practice, our interviews suggest that this is largely dependent
on the facilitating conditions determined by their organisation.
Clinicians are constrained by the health service’s stringent
requirements on app evaluation and ethical considerations.
Nevertheless, the WHO’s advocacy of mobile technology’s
role in healthcare and the establishment of the NHS app
library, suggest that technologies that mitigate the chronic
disease pandemic will be feasible in the near future.
Clinicians explained that target patients are often already ac-
tive in self-monitoring, suggesting that, although such technol-
ogy would be feasible, clinicians also have initial requirements
that must be satisfied by software to justify the disruption
of their current working practices. We briefly discuss these
requirements in relation to the two overarching themes of time
and quality of EUD technologies.
Time appears to be the most critical barrier faced by
clinicians, thus the time EUD would ultimately save (perceived
usefulness) and the time that organisations would allow for
integration (facilitating conditions) are determining factors for
adoption. The NHS, or indeed any organisation that a clinician
is part of, must allocate time for a period of adjustment.
However, an organisation’s willingness to do so is contingent
on the assurance that it will eventually save time, and therefore
money. Empirical evidence of time-saving capabilities through
an NHS-supported evaluation is thus necessary. Although
clinicians will still have limited time to engage in development
activities, patients’ motivation to independently manage their
health suggests that these patients could themselves act as
developers, tailoring their management applications to their
own goals and needs.
Quality is another overarching factor discussed. The quality
of an app in terms of its functionality is a determining adoption
factor (perceived usefulness), but particularly in terms of its
reliability. A reliable app ensures that constant debugging and
patient frustration are minimised, but is also necessary to
ensure that apps will not potentially cause harm by malfunc-
tioning (facilitating conditions). Reliability is another critical
facilitating condition for organisations. Particularly in the
health service, all apps must undergo rigorous evaluation to
ensure that they will do no harm to patients. This is a difficult
implication to address for an EUD tool, given that adoption is
contingent on not just the reliability of one particular app, but
on the reliability of all apps that could be developed. Evidence
that clinicians and patients cannot implement harmful apps is
therefore a necessary adoption factor.
A. Limitations
Although interviews and observation offer insights beyond
that of usability studies, some limitations remain. Half of
the interviewees were GPs, which was a consequence of
convenience sampling in our university’s school of medicine.
It emerged that GPs are minimally involved in chronic disease
management of patients. Nevertheless, all clinicians were well-
informed on the duties of practice nurses and therefore aware
of their potential motivations and constraints. Further work is
required to elicit the firsthand feedback of practice nurses.
Furthermore, unlike the studies in our Related Work section,
we did not receive direct feedback from individuals currently
managing chronic diseases. However, clinicians provided de-
tailed accounts of potential issues and benefits for patients,
which were reflected in the observation of such patients, and
were adequate for addressing adoption factors for clinicians.
Finally, as chronic disease is a global problem, we are
limited in the scope of our research within the UK health
service. Attitudes towards, and understanding of health tech-
nologies will vary widely across different cultures, constituting
an extra dimension of ‘wickedness’. Replicating this work with
international clinicians would provide insight into the breadth
of this variability.
VI. CONCLUSION
EUD platforms can support clinicians and patients to take
charge of chronic disease management at a large and complex
scale, where there is no clearly delineated and agreed solution
for all problem owners. In this paper, we described how
clinicians and patients could employ EUD to improve chronic
disease management at an individual granularity, with require-
ments towards real-world adoption. While significant work is
required to enable a real-world evaluation, our research thus
far suggests a key area of global impact for EUD technologies.
REFERENCES
[1] M. Gusev, A. Stojmenski, and I. Chorbev, “Challenges for development
of an ecg m-health solution,” Journal of Emerging Research and
Solutions in ICT, vol. 1, no. 2, pp. 25–38, 2016.
[2] World Health Organization, “mHealth: New horizons for health through
mobile technologies,” Observatory, vol. 3, pp. 66–71, 2011.
[3] Research2Guidance, “mHealth economics 2017 - current status and
future trends in mobile health,” 2017, accessed August 20th 2018.
[Online]. Available: https://research2guidance.com/product-category/
mhealth/digital-health-market-overview/
[4] M. N. Kamel Boulos, A. C. Brewer, C. Karimkhani, D. B. Buller, and
R. P. Dellavalle, “Mobile medical and health apps: state of the art,
concerns, regulatory control and certification,” Online Journal of Public
Health Informatics, vol. 5, no. 3, p. e229, 2014.
[5] M. E. Hilliard, A. Hahn, A. K. Ridge, M. N. Eakin, and K. A. Riekert,
“User preferences and design recommendations for an mHealth app to
promote cystic fibrosis self-management,” Journal of Medical Internet
Research, vol. 16, no. 10, p. e44, Oct 2014.
[6] L. Simons, A. Z. Valentine, C. J. Falconer, M. Groom, D. Daley, M. P.
Craven, Z. Young, C. Hall, and C. Hollis, “Developing mHealth remote
monitoring technology for attention deficit hyperactivity disorder: a
qualitative study eliciting user priorities and needs,” JMIR mHealth and
uHealth, vol. 4, no. 1, p. e31, Mar 2016.
[7] S. C. Reid, S. D. Kauer, A. S. Khor, S. J. C. Hearps, L. A. Sanci,
A. D. Kennedy, and G. C. Patton, “Using a mobile phone application in
youth mental health: An evaluation study,” Australian Family Physician,
vol. 41, no. 9, pp. 711–714, Dec 2012.
[8] D. Tetteroo, P. Vreugdenhil, I. Grisel, M. Michielsen, E. Kuppens,
D. Vanmulken, and P. Markopoulos, “Lessons learnt from deploying
an end-user development platform for physical rehabilitation,” in Pro-
ceedings of the 33rd Annual ACM Conference on Human Factors in
Computing Systems. ACM, 2015, pp. 4133–4142.
[9] L. A. Jibb, B. J. Stevens, P. C. Nathan, E. Seto, J. A. Cafazzo,
and J. N. Stinson, “A smartphone-based pain management app for
adolescents with cancer: Establishing system requirements and a pain
care algorithm based on literature review, interviews, and consensus,”
Journal of Medical Internet Research, vol. 16, no. 3, p. e15, Mar 2014.
[10] D. Swendeman, S. Farmer, D. Mindry, S.-J. Lee, and M. Medich, “HIV
Care Providers’ Attitudes regarding Mobile Phone Applications and
Web-Based Dashboards to support Patient Self-Management and Care
Coordination: Results from a Qualitative Feasibility Study.” Journal of
HIV and AIDS, vol. 2, no. 4, pp. 1310–1318, Oct 2016.
[11] E. Seto, K. J. Leonard, J. A. Cafazzo, J. Barnsley, C. Masino, and H. J.
Ross, “Developing healthcare rule-based expert systems: Case study of
a heart failure telemonitoring system,” International Journal of Medical
Informatics, vol. 81, no. 8, pp. 556–565, Aug 2012.
[12] J. E. Bardram, M. Frost, K. Sza´nto´, M. Faurholt-Jepsen, M. Vinberg,
and L. V. Kessing, “Designing mobile health technology for bipolar
disorder: a field trial of the monarca system,” in Proceedings of the
SIGCHI Conference on Human Factors in Computing Systems, Paris,
France, 2013, pp. 2627–2636.
[13] S. W. Miyamoto, S. Henderson, H. M. Young, A. Pande, and J. J. Han,
“Tracking Health Data Is Not Enough: A Qualitative Exploration of the
Role of Healthcare Partnerships and mHealth Technology to Promote
Physical Activity and to Sustain Behavior Change,” JMIR mHealth and
uHealth, vol. 4, no. 1, p. e5, Jan 2016.
[14] D. K. King, D. J. Toobert, J. D. Portz, L. A. Strycker, A. Doty, C. Martin,
J. M. Boggs, A. J. Faber, C. R. Geno, and R. E. Glasgow, “What
patients want: relevant health information technology for diabetes self-
management,” Health and Technology, vol. 2, no. 3, Sep 2012.
[15] L. Dennison, L. Morrison, G. Conway, and L. Yardley, “Opportunities
and challenges for smartphone applications in supporting health behavior
change: qualitative study.” Journal of Medical Internet Research, vol. 15,
no. 4, p. e86, Apr 2013.
[16] N. Ramanathan, D. Swendeman, W. S. Comulada, D. Estrin, and M. J.
Rotheram-Borus, “Identifying preferences for mobile health applications
for self-monitoring and self-management: focus group findings from
HIV-positive persons and young mothers,” International journal of
medical informatics, vol. 82, no. 4, pp. e38–e46, 2013.
[17] D. Ben-Zeev, C. J. Brenner, M. Begale, J. Duffecy, D. C. Mohr, and
K. T. Mueser, “Feasibility, acceptability, and preliminary efficacy of
a smartphone intervention for schizophrenia,” Schizophrenia Bulletin,
vol. 40, no. 6, pp. 1244–1253, Nov 2014.
[18] Z. W. Adams, E. A. McClure, K. M. Gray, C. K. Danielson, F. A.
Treiber, and K. J. Ruggiero, “Mobile devices for the remote acquisi-
tion of physiological and behavioral biomarkers in psychiatric clinical
research.” Journal of Psychiatric Research, vol. 85, pp. 1–14, 2017.
[19] F. Naughton, S. Hopewell, N. Lathia, R. Schalbroeck, C. Brown,
C. Mascolo, A. McEwen, and S. Sutton, “A context-sensing mobile
phone app (q sense) for smoking cessation: A mixed-methods study,”
JMIR Mhealth Uhealth, vol. 4, no. 3, p. e106, Sep 2016.
[20] G. F. Dunton, E. Dzubur, K. Kawabata, B. Yanez, B. Bo, and S. Intille,
“Development of a smartphone application to measure physical activity
using sensor-assisted self-report,” Frontiers in Public Health, vol. 2,
p. 12, 2014.
[21] P. Klasnja and W. Pratt, “Healthcare in the pocket: mapping the space of
mobile-phone health interventions,” Journal of Biomedical Informatics,
vol. 45, no. 1, pp. 184–198, 2012.
[22] H. Lieberman, F. Paterno`, M. Klann, and V. Wulf, “End-user develop-
ment: An emerging paradigm,” in End User Development, H. Lieberman,
F. Paterno`, and V. Wulf, Eds. Dordrecht: Springer Netherlands, 2006,
pp. 1–8.
[23] V. Venkatesh, M. G. Morris, G. B. Davis, and F. D. Davis, “User
acceptance of information technology: Toward a unified view,” MIS
Quarterly, vol. 27, no. 3, pp. 425–478, Sep. 2003.
[24] D. Rough and A. Quigley, “End-user development in social psychology
research: Factors for adoption,” in Visual Languages and Human-Centric
Computing (VL/HCC), 2018 IEEE Symposium on. IEEE, 2018, (in
press).
[25] V. Venkatesh and F. D. Davis, “A theoretical extension of the technology
acceptance model: four longitudinal field studies,” Management science,
vol. 46, no. 2, pp. 186–204, 2000.
